Home / Peptide legality / Iowa
Are peptides legal in Iowa?
Iowa has no peptide-specific ban, so peptide legality here follows the federal compounding framework, which makes the honest verdict a gray one rather than a simple legal or illegal.
Legal status overview
Iowa sits in a gray zone because the state defers to the federal compounding framework instead of setting its own peptide rules. FDA-approved products such as Wegovy® (semaglutide) are legal by prescription, while popular research peptides like BPC-157 remain neither FDA-approved nor authorized for compounding. Iowa pharmacies compound under state rules that adopt federal 503A standards and the current USP chapters, so what a pharmacy may legally prepare tracks the FDA bulk substance lists. This is general information, not legal or medical advice.
Key points
- Iowa does not have a statute that names or bans peptides specifically; instead the Iowa Board of Pharmacy regulates them through general compounding rules that incorporate the federal 503A standards and USP chapters. [4]
- Effective July 16, 2025, the Board rescinded its old 657 IAC rules and replaced them with 481 IAC Chapters 550 through 557, with compounding governed by 481 IAC Chapter 552 and USP Chapter 795 (2023) for nonsterile and USP Chapter 797 (2023) for sterile preparations. [4]
- The FDA removed BPC-157 and eleven other peptides from the Category 2 do not compound list on April 15, 2026, but did not add them to the Category 1 authorized bulk substances list, leaving them in a regulatory gray zone nationwide. [1]
- Removal from Category 2 is not a green light; a peptide still needs Category 1 status, FDA approval, or a USP monograph before a 503A pharmacy may lawfully compound it as a bulk substance. [3]
- Wegovy® (semaglutide) and Zepbound® (tirzepatide) are FDA-approved and available by prescription in Iowa; compounded semaglutide and compounded tirzepatide are not FDA-approved, are not a generic, and have not been evaluated by the FDA, and broad compounding largely ended after the 2025 shortage resolutions. [2]
- Iowa pharmacy rules limit compounding a preparation that is essentially a copy of a commercially available approved drug unless the prescriber documents a clinically significant difference for a specific patient. [5]
- Somatropin (human growth hormone) is restricted nationwide by 21 U.S.C. 333(e), which makes distribution for any use other than an FDA-approved indication a federal felony, so anti-aging or performance use is prohibited in Iowa. [6]
Compound-by-compound status
| BPC-157 Gray area | Not FDA-approved and no USP monograph. Removed from the FDA Category 2 do not compound list on April 15, 2026, but not added to the Category 1 authorized list, so it remains a gray-zone substance in Iowa as elsewhere. |
|---|---|
| GLP-1 class (semaglutide, tirzepatide) Restricted | Wegovy® (semaglutide), Ozempic® (semaglutide), Zepbound® (tirzepatide), and Mounjaro® (tirzepatide) are FDA-approved and available by prescription in Iowa. Compounded semaglutide and compounded tirzepatide are not FDA-approved, are not a generic, and have not been evaluated by the FDA; broad compounding was curtailed after the 2025 shortage resolutions. |
| TB-500 (thymosin beta-4 fragment) Gray area | Not FDA-approved and no USP monograph. Removed from Category 2 on April 15, 2026, but not authorized for compounding, so it sits in the same gray zone as BPC-157 in Iowa. |
| Growth hormone / somatropin Restricted | A prescription drug whose distribution is limited by 21 U.S.C. 333(e) to FDA-approved indications ordered by a physician. Distribution for anti-aging, bodybuilding, or general wellness is a federal crime and applies in Iowa. |
Frequently asked questions
Are peptides legal in Iowa?
There is no Iowa law that bans peptides by name. FDA-approved peptide drugs are legal by prescription, but research peptides such as BPC-157 are neither FDA-approved nor authorized for compounding, which places them in a gray zone. This is general information, not legal advice.
Can an Iowa pharmacy compound BPC-157?
Not lawfully as a bulk substance today. The FDA removed BPC-157 from the Category 2 list in April 2026 but did not add it to the Category 1 authorized list, and it has no USP monograph and no FDA approval, so it is not cleared for 503A compounding.
Is compounded semaglutide available in Iowa?
Wegovy® (semaglutide) and Ozempic® (semaglutide) are FDA-approved and available by prescription. Compounded semaglutide is not FDA-approved, is not a generic, and has not been evaluated by the FDA, and broad compounding largely ended after the 2025 shortage resolutions.
What rules govern compounding pharmacies in Iowa?
Since July 2025 the Iowa Board of Pharmacy regulates compounding under 481 IAC Chapter 552, which adopts USP Chapter 795 for nonsterile and USP Chapter 797 for sterile preparations, layered on the federal Drug Quality and Security Act and 503A standards.
Is human growth hormone legal to prescribe for anti-aging in Iowa?
No. Federal law at 21 U.S.C. 333(e) limits somatropin distribution to FDA-approved indications, and the FDA treats writing a prescription as distribution, so anti-aging or performance use is prohibited nationwide, including Iowa.
Sources
- FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List (Frier Levitt) (retrieved 2026-09-21)
- Deep Dive: Regulatory Status of Popular Compounded Peptides (Holt Law) (retrieved 2026-09-21)
- BPC-157 in 2026: Why Regulatory Limbo Is Not the Same as a Green Light (Holt Law) (retrieved 2026-09-21)
- 481 IAC Chapter 552 Compounding (Iowa Administrative Code) (retrieved 2026-09-21)
- Pharmacy Laws and Rules (Iowa Department of Inspections, Appeals, and Licensing) (retrieved 2026-09-21)
- 21 U.S. Code Section 333 Penalties (Legal Information Institute) (retrieved 2026-09-21)
Last researched: 2026-09-21.